Funded by the EU
European Union’s Horizon Europe Research and Innovation Actions
Posted on March 12, 2024 • 1 minutes • 109 words
Table of contents
The European Union
has funded the international research consortium BEHIND-MS as part of its HORIZON Europe programme, which aims to clarify these associations in order to identify specific biomarkers and targeted therapeutic approaches. The consortium, led by the German Cancer Research Center, will receive 7.1 million euros over a period of five years.
Horizon Europe Research and Innovation Actions
Specifically this project has received funding from the European Union’s Horizon Europe Research and Innovation Actions under grant no. 101137235 (BEHIND-MS). It is under the call Relationship between infections and non-communicable diseases (HORIZON-HLTH-2023-DISEASE-03)
Additional Funding
UZH has received funding from the Swiss State Secretariat for Education, Research and lnnovation (SERI).
